Drugs that contain Formoterol Fumarate
1. Foradil patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6488027 | NOVARTIS | Powder inhaler |
Mar, 2019
(5 years ago) | |
| US6887459 | NOVARTIS | Aerosol composition comprising formoterol |
Nov, 2020
(3 years ago) | |
Market Authorisation Date: 16 February, 2001
Treatment: Treatment of chronic obstructive pulmonary disease
Dosage: POWDER;INHALATION
More Information on Dosage
FORADIL family patents
2. Perforomist patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6814953 | MYLAN SPECLT | Bronchodilating compositions and methods |
Jun, 2021
(2 years ago) | |
| US8623922 | MYLAN SPECLT | Bronchodilating Beta-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
| US7348362 | MYLAN SPECLT | Bronchodilating β-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
| US7462645 | MYLAN SPECLT | Bronchodilating beta-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
| US6667344 | MYLAN SPECLT | Bronchodilating compositions and methods |
Jun, 2021
(2 years ago) | |
| US9730890 | MYLAN SPECLT | Bronchodilating beta-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
Market Authorisation Date: 11 May, 2007
Treatment: Maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (copd)
Dosage: SOLUTION;INHALATION
How can I launch a generic of PERFOROMIST before it's drug patent expiration?
More Information on Dosage
PERFOROMIST family patents